These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 4868660)

  • 41. Cardio-circulatory effects of beta-adrenergic blockade in organic heart disease. Comparison between propranolol and CIBA 39,089-Ba.
    Grandjean T; Rivier JL
    Br Heart J; 1968 Jan; 30(1):50-9. PubMed ID: 5637558
    [No Abstract]   [Full Text] [Related]  

  • 42. Human cardiovascular effects of alprenolol, a beta-adrenergic blocker: hemodynamic, antiarrhythmic, and antianginal.
    Wasserman AJ; Proctor JD; Allen FJ; Kemp VE
    J Clin Pharmacol J New Drugs; 1970; 10(1):37-49. PubMed ID: 4391785
    [No Abstract]   [Full Text] [Related]  

  • 43. Inhibition of cardiac chronotropic action of isoproterenol by Sotalol (MJ 1999) in rat, dog and man.
    Lish PM; Shelanski MV; LaBudde JA; Williams WR
    Curr Ther Res Clin Exp; 1967 Jun; 9(6):311-24. PubMed ID: 4963067
    [No Abstract]   [Full Text] [Related]  

  • 44. Effects of propranolol, oxprenolol, and practolol on denervated dog heart.
    Harry JD; Kappagoda CT; Linden RJ; Snow HM
    Br Heart J; 1971 Jul; 33(4):614-5. PubMed ID: 4397631
    [No Abstract]   [Full Text] [Related]  

  • 45. Alprenolol in angina pectoris. A clinical and ergometric study with a new beta-adrenergic blocking agent.
    Arstila M; Iisalo E; Kallio V
    Ann Clin Res; 1969 May; 1(1):13-21. PubMed ID: 4390794
    [No Abstract]   [Full Text] [Related]  

  • 46. Effect of a new adrenergic beta-blocking agent, H 56-28, on nervous heart complaints.
    Nordenfelt I; Persson S; Redfors A
    Acta Med Scand; 1968 Dec; 184(6):465-71. PubMed ID: 4885079
    [No Abstract]   [Full Text] [Related]  

  • 47. Relative potency of intravenous prinodolol and propranolol in man.
    Arbab AG; Hicks DC; Turner P
    Br J Pharmacol; 1971 Aug; 42(4):665P-666P. PubMed ID: 4940273
    [No Abstract]   [Full Text] [Related]  

  • 48. Effects of beta-adrenoceptor blocking drugs on the chronotropic and inotropic actions of isoprenaline on the acutely denervated dog heart.
    Harry JD; Kappagoda CT; Linden RJ; Snow HM
    Br J Pharmacol; 1971 Feb; 41(2):387P-389P. PubMed ID: 4396704
    [No Abstract]   [Full Text] [Related]  

  • 49. Effect of lb 46, a new beta-adrenergic antagonist, in hyperthyroidism. Heart rate and blood pressure at rest and during exercise.
    Runeberg L; Kreus KE
    Acta Med Scand; 1971 May; 189(5):423-6. PubMed ID: 4397076
    [No Abstract]   [Full Text] [Related]  

  • 50. The action of intravenous oxprenolol, practolol, propranolol and sotalol on acute exercise tolerance in angina pectoris: the effect on heart rate and the electrocardiogram.
    Prichard BN; Aellig WH; Richardson GA
    Postgrad Med J; 1970 Nov; ():Suppl:77-85. PubMed ID: 4395464
    [No Abstract]   [Full Text] [Related]  

  • 51. [Effects of 1-4-dihydrazinophthalazine on arterial pressure and heart rate, before and after administration of beta-blocking drugs].
    Campus S; Rappelli A; Fabris F; Mathis I
    Boll Soc Ital Biol Sper; 1967 Dec; 43(24):1847-51. PubMed ID: 5602829
    [No Abstract]   [Full Text] [Related]  

  • 52. Plasma propranolol levels in the quaniitative assessment of beta-adrenergic blockade in man.
    Coltart DJ; Shand DG
    Br Med J; 1970 Sep; 3(5725):731-4. PubMed ID: 4394650
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Beta-blockade and emotional tachycardia; radiotelemetric investigations in ski jumpers.
    Imhof PR; Blatter K; Fuccella LM; Turri M
    J Appl Physiol; 1969 Sep; 27(3):366-9. PubMed ID: 5804134
    [No Abstract]   [Full Text] [Related]  

  • 54. [Influence of adrenergic beta receptor blocking with propranolol on the electrocardiographic changes caused by pitressin].
    Romeo F; Squadrito G; Nicita-Mauro V
    Atti Soc Ital Cardiol; 1968; 2():77-81. PubMed ID: 5743877
    [No Abstract]   [Full Text] [Related]  

  • 55. [The heart rate decreasing activity of the beta-blocker propranolol in various types of tachycardia in conscious dogs (author's transl)].
    Lehmann HD
    Dtsch Tierarztl Wochenschr; 1981 Jun; 88(6):239-41. PubMed ID: 7026215
    [No Abstract]   [Full Text] [Related]  

  • 56. [Clinical studies and experiences with beta-adrenergic blocking agents in the treatment of sinus tachycardia in children].
    Diekmann L
    Arztl Forsch; 1970 Jan; 24(1):13-8. PubMed ID: 4398686
    [No Abstract]   [Full Text] [Related]  

  • 57. Treadmill investigations into the action of beta receptor antagonists on blood pressure and pulse rate.
    Kirchhoff HW
    Int Z Klin Pharmakol Ther Toxikol; 1970 Dec; 4(1):141-4. PubMed ID: 4395479
    [No Abstract]   [Full Text] [Related]  

  • 58. Studies on dl-4-(2-hydroxy-3-isopropylaminopropoxy)-indole A/Giudicelli JF, Schmitt H, Boissier JR: Studies on dl-4-(2-hydroxy-3-isopropylaminopropoxy)-indole (LB 46), a new potent beta adrenergic blocking drug.
    Giudicelli JF; Schmitt H; Boissier JR
    J Pharmacol Exp Ther; 1969 Jul; 168(1):116-26. PubMed ID: 5792677
    [No Abstract]   [Full Text] [Related]  

  • 59. Effect of propranolol on exercise tolerance of patients with atrial fibrillation.
    Brown RW; Goble AJ
    Br Med J; 1969 May; 2(5652):279-80. PubMed ID: 4888876
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of beta-adrenergic receptor blockade on racing performance of greyhounds with normal and with denervated hearts.
    Donald DE; Ferguson DA; Milburn SE
    Circ Res; 1968 Feb; 22(2):127-34. PubMed ID: 5639034
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.